BVNRY:OTCMKTS
巴伐利亞北歐
US$11.96
arrow_upward
+1.53%(+0.18) 1 天
10月12日, GMT-4 16:00:00 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 BVNRY 生成关键数据洞见…
开盘价
US$11.96
最高价
US$11.96
最低价
US$11.96
市值
28.59亿
平均成交量
3098.00
成交量
408.00
市盈率
12.85
52 周最高价
US$13.00
52 周最低价
US$8.67
每股收益
US$0.93
Beta 版
1.45
流通股数
2.38亿
员工人数
1906
开盘价
US$11.96
最高价
US$11.96
最低价
US$11.96
市值
28.59亿
平均成交量
3098.00
成交量
408.00
市盈率
12.85
52 周最高价
US$13.00
52 周最低价
US$8.67
每股收益
US$0.93
Beta 版
1.45
流通股数
2.38亿
员工人数
1906
新闻报道
来自网络来源和新闻合作伙伴
GlobeNewswire
·
17小时前
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
资料
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
巴伐利亞北歐简介